This news release unveils and explains a new surgical device. Since it is a high-tech product, there is a danger of getting lost in the details. This release shows how a potentially complicated subject can be treated simply, and can be readable and interesting in spite of its technical nature.
BILL FREDERICK COMMUNICATIONS INC.
The next revolution in surgery may come
from a small, under-the-radar company
By ARTHUR FREDERICK
CLEARWATER, Fla. (June 7, 2012) — The next revolution in surgery may come from a small medical equipment company which, according to its own executives, has always preferred to fly a bit under the radar.
Bovie Medical Corp., a public company with executive offices in Melville, N.Y. but with labs and manufacturing facilities in Clearwater, Fla., has received permission from the U.S. Food & Drug Administration to begin marketing this summer on a new, non-contact surgical device it calls J-Plasma. Those initial evaluations are expected to take place in several surgical centers around the country.
“We announced the J-Plasma concept several years ago, but the process of getting any new product to market has become increasingly difficult and time-consuming,” said Rob Saron, Bovie Medical’s president. “Because of that, the initial excitement may have waned a bit. But J-Plasma’s time has finally arrived.”
Bovie Medical is known most widely for its cauteries and other electrosurgical products, but it owns three patents for the J-Plasma technology, the first of which was granted in 1999. The latest patent was granted last November.
Three other patents related to the new technology are pending.